Biree Andemariam, MD

Dr. Biree Andemariam is a hematologist and founding director of the New England Sickle Cell Institute (NESCI) at the University of Connecticut Health Center. NESCI was established in 2009 and now serves nearly 300 adults living with sickle cell disease. With a staff of twelve individuals, including nurses, social workers, patient navigators, and research assistants, NESCI provides comprehensive care, acute pain management, specialized blood transfusions, and a destination for children in Connecticut who have aged out of pediatric SCD care.

Dr. Andemariam’s research focuses on developing new pathways of care that improve SCD care quality as well as translational research on deciphering the interplay between red blood cell adhesion to the walls of the circulatory system and the development of pain. She holds an undergraduate degree in molecular biology from Princeton University and a medical degree from Tufts. She is also the Chief Medical Officer of the Sickle Cell Disease Association of America, Inc.

Representative Publications:

Microfluidic experimental setup for adhesion and recovery measurements of red blood cells in sickle cell disease

Regulation of Active ICAM-4 on Normal and Sickle Cell Disease RBCs via AKAPs Is Revealed by AFM

Loss of Bone in Sickle Cell Trait and Sickle Cell Disease Female Mice Is Associated With Reduced IGF-1 in Bone and Serum

Traumatic Exposure History as a Risk Factor for Chronic Pain in Adult Patients with Sickle Cell Disease

Development of a New Adult Sickle Cell Disease Center Within an Academic Cancer Center: Impact on Hospital Utilization Patterns and Care Quality

Patient Controlled Analgesia for Adults with Sickle Cell Disease Awaiting Admission from the Emergency Department